Hospital Photos
The Third People's Hospital of Shenzhen (深圳市第三人民医院) was established in 待查证 in Shenzhen, as a 其他 comprehensive hospital, with professional advantages in National Clinical Research Center for Infectious Diseases (Shenzhen), Viral Hepatitis and Liver Disease Center, HIV/AIDS Diagnosis, Treatment and Follow-up Management Center and other fields.
A clinical research and transformation platform for major emerging and re-emerging infectious diseases, leading multi-center clinical trials and real-world studies, forming an integrated closed loop of 'clinical-testing-research-public health', and providing evidence support for national infectious
Focusing on chronic viral hepatitis such as hepatitis B/C and the management of complications of liver fibrosis and cirrhosis, carrying out individualized antiviral therapy and non-invasive fibrosis assessment, and establishing a multidisciplinary consultation (MDT) channel for liver diseases.
Providing full management of HIV antiretroviral therapy (ART), drug resistance monitoring and MDT diagnosis and treatment of opportunistic infections, building a privacy-friendly follow-up and psychological support system, and carrying out clinical research on new long-acting preparations.
Targeting drug-resistant tuberculosis, complex lung infections and severe pneumonia, integrating imaging, sputum culture/molecular detection and drug sensitivity platforms to provide individualized plans and standardized isolation and hospital infection prevention and control paths.
Equipped with multiple ECMO and advanced respiratory support equipment, establishing rescue processes for ARDS, septic shock, and multiple organ dysfunction, covering transport ECMO and interdisciplinary rescue.
Based on rapid etiological diagnosis of MALDI-TOF, NGS and drug resistance gene profiles, establishing in-hospital drug resistance monitoring outposts and antimicrobial management (AMS) strategies to promote precise drug use.
Relying on BSL-3/P3 laboratories and negative pressure isolation wards, forming an emergency response capability of 'rapid screening-review-graded admission-homogeneous treatment' to support city-level public health event command.
Carrying out precise diagnosis and treatment of infectious diseases in newborns, children and pregnant women, and perinatal prevention and control strategies, standardizing mother-to-child blocking, vaccination and nutritional/immune support.
Integrating whole genome sequencing, metagenomics and single-cell technology to quickly locate pathogens, track transmission chains, and serve clinical decision-making and regional pathogen tracing.
Possessing clinical trial qualifications for drugs and medical devices, carrying out clinical research on new antiviral, anti-infection and immunomodulatory drugs, and promoting the translation of scientific research findings into clinical practice.
International patient treated for relapsed B-cell lymphoma with complete remission after 3 months.
Read More →Patient from the Middle East underwent TAVR procedure with same-day mobilisation.
Read More →Awake craniotomy performed with full language preservation and discharge within 5 days.
Read More →⚕
Used for locating infection foci and assessing inflammatory activity, supports precise imaging of complex fever of unknown origin, cardiovascular/orthopedic implant infections, and systemic disseminat
⚕
Equipped with high temporal resolution and spectral imaging capabilities, performs high-resolution chest scans and spectral analysis at low doses, facilitating rapid assessment of severe pneumonia, pu
⚕
Performs diffusion kurtosis, susceptibility-weighted imaging, and perfusion imaging to accurately assess intracranial infections, spinal infections, and liver fibrosis/inflammatory changes, providing
⚕
Supports the safe isolation, culture, and animal experiments of highly pathogenic pathogens, with airtightness and negative pressure gradient control, and is a core platform for emergency detection an
⚕
Enables metagenomic direct detection, antibiotic resistance gene profiling, and source tracing, significantly shortening the “sample-to-result” time, supporting in-hospital outbreak and regional trans
⚕
Completes pathogen identification and partial drug resistance phenotype prediction within minutes, significantly shortening the window from empirical treatment to targeted therapy.
Let us coordinate the treatment journey with you.
Share your diagnosis, records, and goals so the team can assess your case.
Receive a personalised recommendation based on your condition, budget, and timeline.
Get support with invitation materials and practical travel planning.
The team supports your arrival, appointments, and care coordination in China.
Continue with aftercare planning and remote follow-up after returning home.
Consultation package
From $299
Treatment fee
Varies
Travel costs
Varies
Invitation and travel guidance can be arranged where needed.
Drivers and local transport planning can be coordinated before arrival.
We can suggest hotels or serviced apartments close to the hospital.
“My mother's treatment here gave our family a second chance. The doctors explained every step clearly and the aftercare guidance was detailed and practical.”
Carlos R.
Mexico
“My husband received cardiac treatment here that was not available back home. The doctors were thorough and the nursing care was exceptional throughout his stay.”
Fatima A.
Saudi Arabia
“The team helped me compare options clearly and made treatment travel feel manageable from start to finish.”
Ahmed K.
United Arab Emirates
“Organised, efficient, and genuinely caring. The hospital's international team handled all the logistics so I could focus entirely on recovery.”
Thomas W.
Germany
Tell us about your case and we will connect you with the right specialist at this hospital.